This article presents findings from a study to determine if medical information in patient charts could offer clinical details that would help interpret a claims-based comparative effectiveness study of selective serotonin reuptake inhibitors (SSRIs).

To compare healthcare costs associated with initiating treatment on escitalopram or an alternative selective serotonin reuptake inhibitor.

This article presents findings from a study to determine if medical information in patient charts could offer clinical details that would help interpret a claims-based comparative effectiveness study of selective serotonin reuptake inhibitors (SSRIs).